These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4828058)

  • 1. [Glipizide stimulation of insulin production in the pancreas of the anesthetized dog].
    Lefebvre P; Luyckx A
    Rev Med Liege; 1974 Mar; 29(5):137-9. PubMed ID: 4828058
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulinotropic potency of glipizide in vitro.
    Herchuelz A; Malaisse WJ
    Diabetologia; 1973 Sep; ():309-10. PubMed ID: 4772977
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacodynamic aspects of two sulphonylurea derivatives glipizide and glibenclamide.
    Artini D; Abbiati R; Orsini G; Parenti MA; Bloch K; Daturi S; Mandelli V
    Diabetologia; 1973 Sep; ():311-6. PubMed ID: 4204091
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of glycemia level on insulin secretion caused by an hypoglycemic sulfamide (glisoxepide) in dogs].
    Loubatières AL; Ribes G; Loubatières-Mariani MM
    C R Seances Soc Biol Fil; 1972; 166(8):1047-50. PubMed ID: 4573746
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in blood glucose and insulin in 4 normal subjects after administration of a single dose of glipizide and glibenclamide].
    Rizzi G; Isaia GC
    Minerva Med; 1974 Jan; 65(1):58-9. PubMed ID: 4214132
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A; Ribes G; Mariani MM; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulinotropic action of a new sulfonylurea: gliclazide.
    Malaisse WJ; Leclercq-Meyer V
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):310-4. PubMed ID: 4626523
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinical study of the metabolic effect of a new oral hypoglycemic agent: glipizide.
    Iacono G; Ghionni A; Colucci M; Verde G; Caputo G
    Int J Clin Pharmacol; 1974 Apr; 7(3):225-31. PubMed ID: 4850166
    [No Abstract]   [Full Text] [Related]  

  • 9. Unaltered glucagon secretion after seven days of sulphonylurea administration in normal subjects.
    Marco J; Valverde I
    Diabetologia; 1973 Sep; ():317-9. PubMed ID: 4204092
    [No Abstract]   [Full Text] [Related]  

  • 10. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
    Beyer J; Haupt E; Cordes U; Kutschera J; Schöffling K
    Horm Metab Res; 1973 Jan; 5(1):9-13. PubMed ID: 4196346
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current concepts of the pancreatic and extrapancreatic mechanisms of the action of peroral hypoglycemic sulfonylurea preparations].
    Poltorak VV; Gladkikh AI
    Probl Endokrinol (Mosk); 1985; 31(2):76-85. PubMed ID: 2859589
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of glipizide on the release of insulin in the perfused rat pancreas in vitro.
    Tasaka Y; Sekine M; Sugimoto C; Ogawara H; Shizume K
    Endocrinol Jpn; 1974 Jun; 21(3):279-81. PubMed ID: 4426313
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics as well as metabolism following orally and intravenously administered C14-glipizide, a new antidiabetic.
    Schmidt HA; Schoog M; Schweer KH; Winkler E
    Diabetologia; 1973 Sep; ():320-30. PubMed ID: 4772978
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of glimepiride and glibenclamide on insulin and glucagon secretion by the perfused rat pancreas.
    Ledercq-Meyer V; Akkan AG; Marchand J; Malaisse WJ
    Biochem Pharmacol; 1991 Sep; 42(8):1634-7. PubMed ID: 1930290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypoglycemic effect of glipizide. Study in 20 diabetic patients with low pancreatic insulin reserve].
    Laviada E; Camara M
    Prensa Med Mex; 1973; 38(7):297-302. PubMed ID: 4596814
    [No Abstract]   [Full Text] [Related]  

  • 16. Profile of insulin release due to intrapancreatic glyburide infusion.
    Colwell AR; Zuckerman L
    Diabetes; 1972 Apr; 21(4):209-15. PubMed ID: 4622788
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of a new sulfonylurea on insulin and glucagon secretion in the isolated perfused pancreas].
    Laube H; Fussgänger RD; Schröder KE; Pfeiffer EF
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2186. PubMed ID: 4579624
    [No Abstract]   [Full Text] [Related]  

  • 18. Stimulation of pancreatic polypeptide secretion in the dog by hypoglycemic agent HB 699.
    Ribes G; Trimble ER; Wollheim CB; Blayac JP; Loubatieres-Mariani MM
    Am J Physiol; 1983 Apr; 244(4):E380-4. PubMed ID: 6340523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of glipizide on the surgically altered pancreas.
    Barr JD; Parish ES; Krusch DA; Farris AH; Freedlender AH; Kaiser DL; Hanks JB
    Am J Surg; 1989 Jan; 157(1):103-8. PubMed ID: 2642663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue distribution and metabolism of drugs VI: Effect of second drugs on pancreatic distribution and insulin-releasing activity of sulfonylureas in perfused rat pancreas.
    Okumura K; Arakawa M; Hori R
    J Pharm Sci; 1980 Feb; 69(2):157-9. PubMed ID: 6987371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.